Salvage non-myeloablative allogeneic transplantation after failure of an autologous transplantation in multiple myeloma

被引：0
|
作者：
Qazilbash, MH [1 ]
Saliba, R [1 ]
Mendoza, F [1 ]
Roden, L [1 ]
Hosing, C [1 ]
Couriel, DE [1 ]
Kebriaci, W [1 ]
Popat, U [1 ]
De Lima, M [1 ]
Champlin, RE [1 ]
Giralt, SA [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.358
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
334
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [1] Non-myeloablative allogeneic transplantation as part of salvage therapy for relapse of multiple myeloma after autologous transplantation.
    Hoepfner, S
    Probst, SM
    Breitkreutz, I
    Moehler, T
    Benner, A
    Goldschmidt, H
    Ho, AD
    Goerner, M
    BLOOD, 2002, 100 (11) : 859A - 859A
  • [2] Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
    F Garban
    M Attal
    JF Rossi
    C Payen
    N Fegueux
    JJ Sotto
    Leukemia, 2001, 15 : 642 - 646
  • [3] Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
    Garban, F
    Attal, M
    Rossi, JF
    Payen, C
    Fegueux, N
    Sotto, JJ
    LEUKEMIA, 2001, 15 (04) : 642 - 646
  • [4] NON-MYELOABLATIVE CONDITIONING AND ALLOGENEIC TRANSPLANTATION FOR MULTIPLE MYELOMA
    Osman, K.
    Elliott, B.
    Mandeli, J.
    Scigliano, E.
    Ross-Dodds, V.
    Isola, L.
    Grosskreutz, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 71 - 71
  • [5] Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma
    Osman, Keren
    Elliott, Brian
    Mandeli, John
    Scigliano, Eileen
    Malone, Adriana
    Isola, Luis
    Grosskreutz, Celia
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (04) : 249 - 254
  • [6] Efficacy of bortezomib therapy for extrarnedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation
    Patriarca, FE
    Prosdocimo, S
    Tomadini, V
    Vasciaveo, A
    Bruno, B
    Fanin, B
    HAEMATOLOGICA, 2005, 90 (02) : 278 - 279
  • [7] Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
    L Karlin
    B Arnulf
    S Chevret
    L Ades
    M Robin
    R P De Latour
    M Malphettes
    N Kabbara
    B Asli
    V Rocha
    J P Fermand
    G Socie
    Bone Marrow Transplantation, 2011, 46 : 250 - 256
  • [8] Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
    Karlin, L.
    Arnulf, B.
    Chevret, S.
    Ades, L.
    Robin, M.
    De Latour, R. P.
    Malphettes, M.
    Kabbara, N.
    Asli, B.
    Rocha, V.
    Fermand, J. P.
    Socie, G.
    BONE MARROW TRANSPLANTATION, 2011, 46 (02) : 250 - 256
  • [9] Non-myeloablative allogeneic transplantation in patients with relapsed or refractory multiple myeloma.
    Gerull, S
    Hegenbart, U
    Goerner, M
    Benner, A
    Moehler, T
    Goldschmidt, H
    Ho, AD
    BLOOD, 2004, 104 (11) : 755A - 755A
  • [10] Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation
    Schrier, RW
    Parikh, CR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (04) : 678 - 683
12345